SINGLE-AGENT LENALIDOMIDE FOR THE TREATMENT OF RELAPSED OR REFRACTORY AGGRESSIVE LYMPHOMA PATIENTS

被引：0
|
作者：
Puccini, B. [1 ]
Chitarrelli, I. [1 ]
Antognoli, G. [1 ]
Fabbri, A. [1 ]
Rigacci, L. [1 ]
Lenoci, M. P. [1 ]
Lauria, F. [1 ]
Bosi, A. [1 ]
机构：
[1] Dept Hematol, Florence, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0687
引用
收藏
页码：288 / 288
页数：1
相关论文
共 50 条
  • [1] Combined analysis of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma
    Witzig, Thomas E.
    Vose, Julie
    Zinzani, Pier Luigi
    Habermann, Thomas Matthew
    Tuscano, Joseph M.
    Sinha, Rajni
    Williams, Michael E.
    Drach, Johannes W.
    Ramchandren, Rod
    Besisik, Sevgi Kalayoglu
    Zhang, Lei
    Cicero, Sherri
    Fu, Tommy
    Goy, Andre
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma
    Richardson, Paul
    Jagannath, Sundar
    Hussein, Mohamad
    Berenson, James
    Singhal, Seema
    Irwin, David
    Williams, Stephanie F.
    Bensinger, William
    Badros, Ashraf Z.
    Vescio, Robert
    Kenvin, Laurie
    Yu, Zhinuan
    Olesnyckyj, Marta
    Zeldis, Jerome
    Knight, Robert
    Anderson, Kenneth C.
    [J]. BLOOD, 2009, 114 (04) : 772 - 778
  • [3] Lenalidomide in relapsed/refractory aggressive lymphoma
    Saha, C.
    Marcus, R.
    Devereux, S.
    Bowcock, S.
    De Lord, C.
    Patten, P.
    Aldouri, M.
    Arnott, S.
    Yallop, D.
    Kassam, S.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 55 - 55
  • [4] Single-agent lenalidomide is active in patients with relapsed or refractory aggressive non-Hodgkin lymphoma who received prior stem cell transplantation
    Vose, Julie M.
    Habermann, Thomas M.
    Czuczman, Myron S.
    Zinzani, Pier Luigi
    Reeder, Craig B.
    Tuscano, Joseph M.
    Lossos, Izidore S.
    Li, Ju
    Pietronigro, Dennis
    Witzig, Thomas E.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (05) : 639 - 647
  • [5] Single-Agent Lenalidomide for Patients with Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma Who Had Received Prior Stem Cell Transplant.
    Vose, Julie M.
    Habermann, Thomas
    Czuczman, Myron S.
    Zinzani, Pier Luigi
    Reeder, Craig B.
    Tuscano, Joseph
    Lossos, Izidore S.
    Pietronigros, Dennis
    Ervin-Hayness, Annette
    Witzig, Thomas
    [J]. BLOOD, 2009, 114 (22) : 1056 - 1056
  • [6] An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma
    Witzig, T. E.
    Vose, J. M.
    Zinzani, P. L.
    Reeder, C. B.
    Buckstein, R.
    Polikoff, J. A.
    Bouabdallah, R.
    Haioun, C.
    Tilly, H.
    Guo, P.
    Pietronigro, D.
    Ervin-Haynes, A. L.
    Czuczman, M. S.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (07) : 1622 - 1627
  • [7] Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma
    Michael Wang
    Simon Rule
    Pier Luigi Zinzani
    Andre Goy
    Olivier Casasnovas
    Stephen D. Smith
    Gandhi Damaj
    Jeanette K. Doorduijn
    Thierry Lamy
    Franck Morschhauser
    Carlos Panizo
    Bijal Shah
    Andrew Davies
    Richard Eek
    Jehan Dupuis
    Eric Jacobsen
    Arnon P. Kater
    Steven Le Gouill
    Lucie Oberic
    Tadeusz Robak
    Preetesh Jain
    Melanie M. Frigault
    Raquel Izumi
    Dorothy Nguyen
    Priti Patel
    Ming Yin
    Monika Długosz-Danecka
    [J]. Leukemia, 2019, 33 : 2762 - 2766
  • [8] Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma
    Wang, Michael
    Rule, Simon
    Zinzani, Pier Luigi
    Goy, Andre
    Casasnovas, Olivier
    Smith, Stephen D.
    Damaj, Gandhi
    Doorduijn, Jeanette K.
    Lamy, Thierry
    Morschhauser, Franck
    Panizo, Carlos
    Shah, Bijal
    Davies, Andrew
    Eek, Richard
    Dupuis, Jehan
    Jacobsen, Eric
    Kater, Arnon P.
    Le Gouill, Steven
    Oberic, Lucie
    Robak, Tadeusz
    Jain, Preetesh
    Frigault, Melanie M.
    Izumi, Raquel
    Dorothy Nguyen
    Patel, Priti
    Yin, Ming
    Dlugosz-Danecka, Monika
    [J]. LEUKEMIA, 2019, 33 (11) : 2762 - 2766
  • [9] Final analysis of MM-014: Single-agent lenalidomide in patients with relapsed and refractory multiple myeloma
    Hussein, M. A.
    Richardson, P. G.
    Jagannath, S.
    Singhal, S.
    Bensinger, W.
    Knight, R.
    Zeldis, J. B.
    Yu, Z.
    Olesnyckyj, M.
    Anderson, K. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Long-term analysis of phase II studies of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma
    Witzig, Thomas E.
    Zinzani, Pier Luigi
    Habermann, Thomas M.
    Tuscano, Joseph M.
    Drach, Johannes
    Ramchandren, Radhakrishnan
    Besisik, Sevgi Kalayoglu
    Takeshita, Kenichi
    Bravo, Marie-Laure Casadebaig
    Zhang, Lei
    Fu, Tommy
    Goy, Andre
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (10) : E575 - E583
12345